We have shown that the Simoa IL-1β 3.0 assay provided the greatest sensitivity in distinguishing IL-1β levels in the serum of AD patients and HC subjects when compared to the S-Plex and V-Plex assays. This evidence concerns the gene IL1B and Alzheimer disease.